The Biden administration identified 43 drugs subject to rebates from manufacturers to Medicare and lower coinsurance rates for beneficiaries starting July 1 -- more than double the current number. Host Kelly Hooper talks with Robert King about the Centers for Medicare and Medicaid Services' decision.
Learn more about your ad choices. Visit megaphone.fm/adchoices
